Correction (DOI:10.1016/j.ajo.2008.08.022);Flare-up Rates with Bimatoprost Therapy in Uveitic Glaucoma

American Journal of Ophthalmology

Volumn 146, Issue 6, 2008, Pages 876-882

  Fortuna, Egidio ^a   Castañeda Cervantes, Rene A ^a   Bhat, Pooja ^a   Doctor, Priyanka ^a   Foster, C Stephen ^a  

^a MASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BIMATOPROST; BRIMONIDINE; BROMFENAC; CARBONATE DEHYDRATASE INHIBITOR; DICLOFENAC; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; FLURBIPROFEN; LATANOPROST; LEVOBUNOLOL; LOTEPREDNOL ETABONATE; NEPAFENAC; PREDNISOLONE; TIMOLOL; TRAVOPROST;

ADD ON THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; KAPLAN MEIER METHOD; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; UNSPECIFIED SIDE EFFECT; UVEITIS;

EID: 56249088317     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2009.01.001     Document Type: Erratum

References (20)

1. Takahashi T., Ohtani S., Miyata K., et al. A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol 46 (2002) 556-562
2. De Boer J., Wulffraat N., and Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol 87 (2003) 879-884
3. Moorthy R.S., Mermoud A., Baerveldt G., et al. Glaucoma associated with uveitis. Surv Ophthalmol 41 (1997) 361-394
4. Heinz C., Koch J.M., and Heiligenhaus A. Transscleral diode laser cyclophotocoagulation as primary surgical treatment for secondary glaucoma in juvenile idiopathic arthritis: high failure rate after short-term follow-up. Br J Ophthalmol 90 (2006) 737-740
5. Warwar R.E., Bullock J.D., and Ballal D. Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients. Ophthalmology 105 (1998) 263-268
6. Waheed K., and Laganowski H. Bilateral poliosis and granulomatous anterior uveitis associated with latanoprost use and apparent hypotrichosis on its withdrawal. Eye 15 (2001) 347-349
7. Fechtner R.D., Khouri A.S., Zimmerman T.J., et al. Anterior uveitis associated with latanoprost. Am J Ophthalmol 126 (1998) 37-41
8. Parentin F. Granulomatous anterior uveitis associated with bimatoprost. A case report. Ocul Immunol Inflamm 11 (2003) 67-71
9. Woodward D.F., Krauss A.H., Chen J., et al. The pharmacology of bimatoprost (Lumigan). Surv Ophthalmol 45 (2001) S337-S345 [erratum] Surv Ophthalmol 2002;47:295
10. Brubaker R.F. Mechanism of action of bimatoprost (Lumigan). Surv Ophthalmol 45 (2001) S347-S351
11. Foster C.S., Harper S.L., and Church III L.J. Principles of diagnosis and therapy. In: Foster C.S., and Vitale A.T. (Eds). Diagnosis and Treatment of Uveitis (2002), W. B. Saunders, Philadelphia, Pennsylvania 79-103
12. Cook J.A., Geisel J., Halushka P.V., and Reines H.D. Prostaglandins, thromboxanes, leukotrienes, and cytochrome P-450 metabolites of arachidonic acid. New Horiz 1 (1993) 60-69
13. Eakins K. Prostaglandin and non-prostaglandin mediated breakdown of blood-aqueous barrier. Exp Eye Res 25 (1977) 483-498
14. Yousufzai S.Y., Ye Z., and Abdel-latif A.A. Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and mammalian species. Exp Eye Res 63 (1996) 305-310
15. Kozawa O., Tokuda H., Miwa M., et al. Mechanism of prostaglandin E2-induced arachidonic acid release in osteoblast-like cells: independence from phosphoinositide hydrolysis. Prostaglandins Leukot Essent Fatty Acids 46 (1992) 291-295
16. Smith S.L., Pruitt C.A., Sine C.S., et al. Latanoprost 0.005% and anterior segment uveitis. Acta Ophthalmol Scand 77 (1999) 668-672
17. Christiansen G.A., Nau C.B., McLaren J.W., and Johnson D.H. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma. Ophthalmology 111 (2004) 1658-1662
18. Richter M., Krauss A.H., Woodward D.F., and Lütjen-Drecoll E. Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide. Invest Ophthalmol Vis Sci 44 (2003) 4419-4426
19. Martin E., Martinez-de-la-Casa J.M., Garcia-Feijoo J., et al. A 6-month assessment of bimatoprost vs timolol maleate: hypotensive efficacy, macular thickness and flare in ocular hypertensive and glaucoma patients. Eye 21 (2007) 164-168
20. Guignard S., Gossec L., Salliot C., et al. Efficacy of tumor necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study. Ann Rheum Dis 65 (2006) 1631-1634